Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Gastroenterol. 2012 Nov 28;48(10):1151–1159. doi: 10.1007/s00535-012-0715-8

Table 4.

OCP–NAFLD association by race, premenopausal women aged 20–60 years in NHANES III (N = 4338), 1988–1994

Non-Hispanic white
Non-Hispanic black
Mexican-American
Others
AORa 95 % CI AORa 95 % CI AORa 95 % CI AORa 95 % CI
OCP use
 Never 1 0.46 0.25, 0.84b 1.60 0.96, 2.69 1.30 0.60, 2.81
 Former* 0.74 0.41, 1.33 0.77 0.43, 1.40 1.30 0.75, 2.24 0.87 0.31, 2.47
 Current* 0.41 0.18, 0.97c 0.68 0.26, 1.82 1.01 0.55, 1.85 0.61 0.15, 2.44

AOR adjusted odds ratio, CI confidence interval, OCP oral contraceptive pill

*

P values for interaction: 0.024 for former versus never users; 0.011 for current versus never users

a

Adjusted for age, smoking status, history of diabetes or hypertension and highest educational level

b

P value for interaction 0.04

c

P value for interaction 0.017